Sodium pyruvate, BioXtra, >=99%

Sodium pyruvate, BioXtra, >=99%

Application

Sodium pyruvate has been used as a component:of cutting solution for rat brain tissue slice preparationof M-199 medium for the maturation of oocytesof Krebs-Henseleit buffer for plasma incubation

Biochem/physiol Actions

Sodium pyruvate based therapeutic regimen is effective for treating mitochondrial diseases. It decreases tissue damage associated with the pathophysiology of brain damage, haemorrhagic shock and ischemia-reperfusion injury models.

Packaging

5, 25, 100 g in poly bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Pack mp InChI key InChI Manufacturer Impurities Form Assay Price Quantity
3572193 Sodium pyruvate, BioXtra, >=99% 100G >300 °C (lit.) DAEPDZWVDSPTHF-UHFFFAOYSA-M 1S/C3H4O3.Na/c1-2(4)3(5)6;/h1H3,(H,5,6);/q;+1/p-1 SIGMA-ALDRICH ≤0.1% Insoluble matter, ≤0.005% Phosphorus (P) powder ≥99%
£475.00 (exc VAT) per 100G
-
+
3572194 Sodium pyruvate, BioXtra, >=99% 25G >300 °C (lit.) DAEPDZWVDSPTHF-UHFFFAOYSA-M 1S/C3H4O3.Na/c1-2(4)3(5)6;/h1H3,(H,5,6);/q;+1/p-1 SIGMA-ALDRICH ≤0.1% Insoluble matter, ≤0.005% Phosphorus (P) powder ≥99%
£123.23 (exc VAT) per 25G
-
+
3572195 Sodium pyruvate, BioXtra, >=99% 5G >300 °C (lit.) DAEPDZWVDSPTHF-UHFFFAOYSA-M 1S/C3H4O3.Na/c1-2(4)3(5)6;/h1H3,(H,5,6);/q;+1/p-1 SIGMA-ALDRICH ≤0.1% Insoluble matter, ≤0.005% Phosphorus (P) powder ≥99%
£64.19 (exc VAT) per 5G
-
+